CONMED Corporation
CNMD
$50.41
$0.591.18%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.33% | -1.31% | 7.88% | 6.70% | 3.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.33% | -1.31% | 7.88% | 6.70% | 3.09% |
| Cost of Revenue | -9.67% | -4.64% | 32.09% | 7.77% | 3.81% |
| Gross Profit | 8.52% | 1.27% | -10.44% | 5.88% | 2.50% |
| SG&A Expenses | 2.40% | -7.87% | 2.26% | 9.64% | 3.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.39% | -4.88% | 17.88% | 8.37% | 3.34% |
| Operating Income | 29.41% | 44.24% | -48.26% | -5.27% | 1.11% |
| Income Before Tax | 4.77% | 139.25% | -32.97% | -92.43% | -20.25% |
| Income Tax Expenses | -2.61% | 176.71% | 26.57% | -81.07% | 12.74% |
| Earnings from Continuing Operations | 7.70% | 129.09% | -50.41% | -94.16% | -28.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.70% | 129.09% | -50.41% | -94.16% | -28.54% |
| EBIT | 29.41% | 44.24% | -48.26% | -5.27% | 1.11% |
| EBITDA | 20.73% | 26.22% | -35.12% | -2.48% | 2.06% |
| EPS Basic | 10.87% | 131.97% | -50.49% | -94.18% | -28.85% |
| Normalized Basic EPS | 52.04% | 78.97% | -55.57% | -1.65% | 5.71% |
| EPS Diluted | 11.20% | 136.84% | -49.97% | -94.27% | -28.13% |
| Normalized Diluted EPS | 52.31% | 79.87% | -55.34% | -1.13% | 6.35% |
| Average Basic Shares Outstanding | -2.84% | -1.24% | 0.15% | 0.32% | 0.44% |
| Average Diluted Shares Outstanding | -3.02% | -1.70% | -0.37% | -0.20% | -0.17% |
| Dividend Per Share | -- | -- | -100.00% | 0.00% | 0.00% |
| Payout Ratio | -- | -- | 1.02% | 16.21% | 0.41% |